TikTok CEO Shou Zi Chew said on Wednesday that artificial intelligence will deliver major scientific breakthroughs within the next three years. The prediction, made during a keynote at a tech conference in Singapore, points to a near-term horizon for discoveries that could reshape entire industries.
Chew didn't name specific fields, but he framed the coming wave as one that will force companies to rethink how they operate. "We're going to see breakthroughs in the next three years that will redefine what's possible," he told the audience, according to a transcript released by conference organizers.
The three-year window and what it means
Chew's timeline is aggressive. It implies that AI-driven research—from drug discovery to materials science—will move from lab experiments to real-world applications by 2027 or so. That's a bet on both the speed of AI development and the ability of industries to adopt it quickly.
If he's right, the implications are huge. Drug companies could compress years of R&D into months. Manufacturers could design new alloys or batteries with AI-generated candidates. But Chew didn't offer a road map. He didn't say which sectors would be first or what kind of breakthroughs he expects.
Why credibility is on the line
The forecast puts Chew and other tech leaders in a tricky spot. Setting a public deadline invites scrutiny. If the breakthroughs don't materialize, it could erode trust in their strategic visions—and in AI hype more broadly.
Chew is far from the only executive making bold AI predictions. But his role at TikTok, a company that's already under intense scrutiny from regulators, adds a layer of risk. Every promise he makes is weighed against the platform's existing challenges.
For now, the tech world is watching. Chew's three-year window starts now.
The industries in the crosshairs
Chew didn't specify which industries would be transformed, but the sectors most likely to feel the impact are those where AI can process massive datasets and generate novel hypotheses. That includes pharmaceuticals, where AI is already being used to identify drug candidates; materials science, where AI can simulate new compounds; and energy, where it can optimize grids and storage.
Each of these fields has its own pace of adoption. Regulations, legacy infrastructure, and cost structures can slow things down. A breakthrough in the lab doesn't automatically translate into a product on the shelf. Chew's prediction assumes that gap can be closed quickly.
What could go wrong
The biggest risk to Chew's forecast is unmet expectations. If AI delivers incremental improvements instead of breakthroughs, the narrative shifts from revolution to evolution. That can still be valuable, but it doesn't generate the same excitement—or the same stock premiums.
Tech leaders have made grand predictions before. Some have panned out; others haven't. Chew's three-year timeline will be easy to track. By 2027, we'll know whether he was prescient or just optimistic.
For now, the clock is ticking. Chew and his peers have staked their credibility on a near-term AI revolution. The next three years will show if they can deliver.
